Status:
COMPLETED
Pethidine Analgesia and Neonatal Hearing Screening Test
Lead Sponsor:
Kanuni Sultan Suleyman Training and Research Hospital
Conditions:
Hearing Loss
Newborn Complication
Eligibility:
FEMALE
24-14 years
Brief Summary
Neonatal hearing screening may fail due to some perinatal and neonatal factors. It is well known that false positivity in newborn hearing screening increases cost and maternal anxiety and anxiety. The...
Detailed Description
The study group consisted of patients receiving 50 mg intramuscular (I.M) pethidine at the beginning of the active phase of labor and the control group consisted of patients not receiving pethidine. N...
Eligibility Criteria
Inclusion
- term singleton pregnancy,
- Gave birth at 37-41 weeks of gestation,
- without chronic internal disease,
- Pregnant women were included in the study.
Exclusion
- Newborn hospitalized in intensive care,
- congenital / chromosomal anomaly,
- congenital CMV infection,
- facial / ear deformities,
- family with hearing problems,
- those with hyperbilirunemia,
- tested at \<12 hours after birth,
- maternal infection,
- Diabetes mellitus, recurrent abortion,
- smoking,
- plesanta previa,
- prolonged premature rupture of the membrane (more than 12 hours), epidural -analgesia and
- newborns who were at risk of asphyxia hypoxia were excluded from the study.
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2018
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04014504
Start Date
January 1 2017
End Date
January 1 2018
Last Update
July 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kanuni Sultan Süleyman Training and Research Hospital
Istanbul, Turkey (Türkiye), 33404